Global Immuno-oncology Therapy Supply, Demand and Key Producers, 2023-2029

Description

Cancer immunotherapy (sometimes called immuno-oncology) is the use of the immune system to treat cancer.

This report studies the global Immuno-oncology Therapy demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Immuno-oncology Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Immuno-oncology Therapy that contribute to its increasing demand across many markets.

The global Immuno-oncology Therapy market size is expected to reach $ 1704.3 million by 2029, rising at a market growth of 4.3% CAGR during the forecast period (2023-2029).

Highlights and key features of the study
Global Immuno-oncology Therapy total market, 2018-2029, (USD Million)
Global Immuno-oncology Therapy total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Immuno-oncology Therapy total market, key domestic companies and share, (USD Million)
Global Immuno-oncology Therapy revenue by player and market share 2018-2023, (USD Million)
Global Immuno-oncology Therapy total market by Type, CAGR, 2018-2029, (USD Million)
Global Immuno-oncology Therapy total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Immuno-oncology Therapy market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen, AstraZeneca, Bristol-Myers Squibb, Eli-Lilly, Roche, GlaxoSmithKline, Janssen Biotech, Merck and Novartis, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Immuno-oncology Therapy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Immuno-oncology Therapy Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Immuno-oncology Therapy Market, Segmentation by Type
    Monoclonal Antibodies
    Immune Checkpoint Inhibitors
    Immune System Modulators
    Cancer Vaccines

Global Immuno-oncology Therapy Market, Segmentation by Application
    Hospitals
    Ambulatory Surgical Center
    Others

Companies Profiled:
    Amgen
    AstraZeneca
    Bristol-Myers Squibb
    Eli-Lilly
    Roche
    GlaxoSmithKline
    Janssen Biotech
    Merck
    Novartis
    Pfizer
    Sanofi
    Spectrum Pharmaceuticals
    Takeda
    BioNTech SE
    Allogene Therapeutics
    IMAB-I-Mab Biopharma Co., Ltd.
    Arcus Biosciences
    Gritstone Oncology
    Autolus Therapeutics
    Rubius Therapeutics

Key Questions Answered
1. How big is the global Immuno-oncology Therapy market?
2. What is the demand of the global Immuno-oncology Therapy market?
3. What is the year over year growth of the global Immuno-oncology Therapy market?
4. What is the total value of the global Immuno-oncology Therapy market?
5. Who are the major players in the global Immuno-oncology Therapy market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Immuno-oncology Therapy Introduction
    1.2 World Immuno-oncology Therapy Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Immuno-oncology Therapy Total Market by Region (by Headquarter Location)
        1.3.1 World Immuno-oncology Therapy Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Immuno-oncology Therapy Market Size (2018-2029)
        1.3.3 China Immuno-oncology Therapy Market Size (2018-2029)
        1.3.4 Europe Immuno-oncology Therapy Market Size (2018-2029)
        1.3.5 Japan Immuno-oncology Therapy Market Size (2018-2029)
        1.3.6 South Korea Immuno-oncology Therapy Market Size (2018-2029)
        1.3.7 ASEAN Immuno-oncology Therapy Market Size (2018-2029)
        1.3.8 India Immuno-oncology Therapy Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Immuno-oncology Therapy Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Immuno-oncology Therapy Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Immuno-oncology Therapy Consumption Value (2018-2029)
    2.2 World Immuno-oncology Therapy Consumption Value by Region
        2.2.1 World Immuno-oncology Therapy Consumption Value by Region (2018-2023)
        2.2.2 World Immuno-oncology Therapy Consumption Value Forecast by Region (2024-2029)
    2.3 United States Immuno-oncology Therapy Consumption Value (2018-2029)
    2.4 China Immuno-oncology Therapy Consumption Value (2018-2029)
    2.5 Europe Immuno-oncology Therapy Consumption Value (2018-2029)
    2.6 Japan Immuno-oncology Therapy Consumption Value (2018-2029)
    2.7 South Korea Immuno-oncology Therapy Consumption Value (2018-2029)
    2.8 ASEAN Immuno-oncology Therapy Consumption Value (2018-2029)
    2.9 India Immuno-oncology Therapy Consumption Value (2018-2029)

3 World Immuno-oncology Therapy Companies Competitive Analysis
    3.1 World Immuno-oncology Therapy Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Immuno-oncology Therapy Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Immuno-oncology Therapy in 2022
        3.2.3 Global Concentration Ratios (CR8) for Immuno-oncology Therapy in 2022
    3.3 Immuno-oncology Therapy Company Evaluation Quadrant
    3.4 Immuno-oncology Therapy Market: Overall Company Footprint Analysis
        3.4.1 Immuno-oncology Therapy Market: Region Footprint
        3.4.2 Immuno-oncology Therapy Market: Company Product Type Footprint
        3.4.3 Immuno-oncology Therapy Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Immuno-oncology Therapy Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Immuno-oncology Therapy Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Immuno-oncology Therapy Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Immuno-oncology Therapy Consumption Value Comparison
        4.2.1 United States VS China: Immuno-oncology Therapy Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Immuno-oncology Therapy Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Immuno-oncology Therapy Companies and Market Share, 2018-2023
        4.3.1 United States Based Immuno-oncology Therapy Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Immuno-oncology Therapy Revenue, (2018-2023)
    4.4 China Based Companies Immuno-oncology Therapy Revenue and Market Share, 2018-2023
        4.4.1 China Based Immuno-oncology Therapy Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Immuno-oncology Therapy Revenue, (2018-2023)
    4.5 Rest of World Based Immuno-oncology Therapy Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Immuno-oncology Therapy Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Immuno-oncology Therapy Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Immuno-oncology Therapy Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Monoclonal Antibodies
        5.2.2 Immune Checkpoint Inhibitors
        5.2.3 Immune System Modulators
        5.2.4 Cancer Vaccines
    5.3 Market Segment by Type
        5.3.1 World Immuno-oncology Therapy Market Size by Type (2018-2023)
        5.3.2 World Immuno-oncology Therapy Market Size by Type (2024-2029)
        5.3.3 World Immuno-oncology Therapy Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Immuno-oncology Therapy Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hospitals
        6.2.2 Ambulatory Surgical Center
        6.2.3 Others
    6.3 Market Segment by Application
        6.3.1 World Immuno-oncology Therapy Market Size by Application (2018-2023)
        6.3.2 World Immuno-oncology Therapy Market Size by Application (2024-2029)
        6.3.3 World Immuno-oncology Therapy Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Amgen
        7.1.1 Amgen Details
        7.1.2 Amgen Major Business
        7.1.3 Amgen Immuno-oncology Therapy Product and Services
        7.1.4 Amgen Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Amgen Recent Developments/Updates
        7.1.6 Amgen Competitive Strengths & Weaknesses
    7.2 AstraZeneca
        7.2.1 AstraZeneca Details
        7.2.2 AstraZeneca Major Business
        7.2.3 AstraZeneca Immuno-oncology Therapy Product and Services
        7.2.4 AstraZeneca Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 AstraZeneca Recent Developments/Updates
        7.2.6 AstraZeneca Competitive Strengths & Weaknesses
    7.3 Bristol-Myers Squibb
        7.3.1 Bristol-Myers Squibb Details
        7.3.2 Bristol-Myers Squibb Major Business
        7.3.3 Bristol-Myers Squibb Immuno-oncology Therapy Product and Services
        7.3.4 Bristol-Myers Squibb Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Bristol-Myers Squibb Recent Developments/Updates
        7.3.6 Bristol-Myers Squibb Competitive Strengths & Weaknesses
    7.4 Eli-Lilly
        7.4.1 Eli-Lilly Details
        7.4.2 Eli-Lilly Major Business
        7.4.3 Eli-Lilly Immuno-oncology Therapy Product and Services
        7.4.4 Eli-Lilly Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Eli-Lilly Recent Developments/Updates
        7.4.6 Eli-Lilly Competitive Strengths & Weaknesses
    7.5 Roche
        7.5.1 Roche Details
        7.5.2 Roche Major Business
        7.5.3 Roche Immuno-oncology Therapy Product and Services
        7.5.4 Roche Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Roche Recent Developments/Updates
        7.5.6 Roche Competitive Strengths & Weaknesses
    7.6 GlaxoSmithKline
        7.6.1 GlaxoSmithKline Details
        7.6.2 GlaxoSmithKline Major Business
        7.6.3 GlaxoSmithKline Immuno-oncology Therapy Product and Services
        7.6.4 GlaxoSmithKline Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 GlaxoSmithKline Recent Developments/Updates
        7.6.6 GlaxoSmithKline Competitive Strengths & Weaknesses
    7.7 Janssen Biotech
        7.7.1 Janssen Biotech Details
        7.7.2 Janssen Biotech Major Business
        7.7.3 Janssen Biotech Immuno-oncology Therapy Product and Services
        7.7.4 Janssen Biotech Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Janssen Biotech Recent Developments/Updates
        7.7.6 Janssen Biotech Competitive Strengths & Weaknesses
    7.8 Merck
        7.8.1 Merck Details
        7.8.2 Merck Major Business
        7.8.3 Merck Immuno-oncology Therapy Product and Services
        7.8.4 Merck Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Merck Recent Developments/Updates
        7.8.6 Merck Competitive Strengths & Weaknesses
    7.9 Novartis
        7.9.1 Novartis Details
        7.9.2 Novartis Major Business
        7.9.3 Novartis Immuno-oncology Therapy Product and Services
        7.9.4 Novartis Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Novartis Recent Developments/Updates
        7.9.6 Novartis Competitive Strengths & Weaknesses
    7.10 Pfizer
        7.10.1 Pfizer Details
        7.10.2 Pfizer Major Business
        7.10.3 Pfizer Immuno-oncology Therapy Product and Services
        7.10.4 Pfizer Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Pfizer Recent Developments/Updates
        7.10.6 Pfizer Competitive Strengths & Weaknesses
    7.11 Sanofi
        7.11.1 Sanofi Details
        7.11.2 Sanofi Major Business
        7.11.3 Sanofi Immuno-oncology Therapy Product and Services
        7.11.4 Sanofi Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 Sanofi Recent Developments/Updates
        7.11.6 Sanofi Competitive Strengths & Weaknesses
    7.12 Spectrum Pharmaceuticals
        7.12.1 Spectrum Pharmaceuticals Details
        7.12.2 Spectrum Pharmaceuticals Major Business
        7.12.3 Spectrum Pharmaceuticals Immuno-oncology Therapy Product and Services
        7.12.4 Spectrum Pharmaceuticals Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 Spectrum Pharmaceuticals Recent Developments/Updates
        7.12.6 Spectrum Pharmaceuticals Competitive Strengths & Weaknesses
    7.13 Takeda
        7.13.1 Takeda Details
        7.13.2 Takeda Major Business
        7.13.3 Takeda Immuno-oncology Therapy Product and Services
        7.13.4 Takeda Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 Takeda Recent Developments/Updates
        7.13.6 Takeda Competitive Strengths & Weaknesses
    7.14 BioNTech SE
        7.14.1 BioNTech SE Details
        7.14.2 BioNTech SE Major Business
        7.14.3 BioNTech SE Immuno-oncology Therapy Product and Services
        7.14.4 BioNTech SE Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.14.5 BioNTech SE Recent Developments/Updates
        7.14.6 BioNTech SE Competitive Strengths & Weaknesses
    7.15 Allogene Therapeutics
        7.15.1 Allogene Therapeutics Details
        7.15.2 Allogene Therapeutics Major Business
        7.15.3 Allogene Therapeutics Immuno-oncology Therapy Product and Services
        7.15.4 Allogene Therapeutics Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.15.5 Allogene Therapeutics Recent Developments/Updates
        7.15.6 Allogene Therapeutics Competitive Strengths & Weaknesses
    7.16 IMAB-I-Mab Biopharma Co., Ltd.
        7.16.1 IMAB-I-Mab Biopharma Co., Ltd. Details
        7.16.2 IMAB-I-Mab Biopharma Co., Ltd. Major Business
        7.16.3 IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Product and Services
        7.16.4 IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.16.5 IMAB-I-Mab Biopharma Co., Ltd. Recent Developments/Updates
        7.16.6 IMAB-I-Mab Biopharma Co., Ltd. Competitive Strengths & Weaknesses
    7.17 Arcus Biosciences
        7.17.1 Arcus Biosciences Details
        7.17.2 Arcus Biosciences Major Business
        7.17.3 Arcus Biosciences Immuno-oncology Therapy Product and Services
        7.17.4 Arcus Biosciences Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.17.5 Arcus Biosciences Recent Developments/Updates
        7.17.6 Arcus Biosciences Competitive Strengths & Weaknesses
    7.18 Gritstone Oncology
        7.18.1 Gritstone Oncology Details
        7.18.2 Gritstone Oncology Major Business
        7.18.3 Gritstone Oncology Immuno-oncology Therapy Product and Services
        7.18.4 Gritstone Oncology Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.18.5 Gritstone Oncology Recent Developments/Updates
        7.18.6 Gritstone Oncology Competitive Strengths & Weaknesses
    7.19 Autolus Therapeutics
        7.19.1 Autolus Therapeutics Details
        7.19.2 Autolus Therapeutics Major Business
        7.19.3 Autolus Therapeutics Immuno-oncology Therapy Product and Services
        7.19.4 Autolus Therapeutics Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.19.5 Autolus Therapeutics Recent Developments/Updates
        7.19.6 Autolus Therapeutics Competitive Strengths & Weaknesses
    7.20 Rubius Therapeutics
        7.20.1 Rubius Therapeutics Details
        7.20.2 Rubius Therapeutics Major Business
        7.20.3 Rubius Therapeutics Immuno-oncology Therapy Product and Services
        7.20.4 Rubius Therapeutics Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.20.5 Rubius Therapeutics Recent Developments/Updates
        7.20.6 Rubius Therapeutics Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Immuno-oncology Therapy Industry Chain
    8.2 Immuno-oncology Therapy Upstream Analysis
    8.3 Immuno-oncology Therapy Midstream Analysis
    8.4 Immuno-oncology Therapy Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Immuno-oncology Therapy Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Immuno-oncology Therapy Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Immuno-oncology Therapy Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Immuno-oncology Therapy Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Immuno-oncology Therapy Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Immuno-oncology Therapy Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Immuno-oncology Therapy Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Immuno-oncology Therapy Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Immuno-oncology Therapy Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Immuno-oncology Therapy Players in 2022
    Table 12. World Immuno-oncology Therapy Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Immuno-oncology Therapy Company Evaluation Quadrant
    Table 14. Head Office of Key Immuno-oncology Therapy Player
    Table 15. Immuno-oncology Therapy Market: Company Product Type Footprint
    Table 16. Immuno-oncology Therapy Market: Company Product Application Footprint
    Table 17. Immuno-oncology Therapy Mergers & Acquisitions Activity
    Table 18. United States VS China Immuno-oncology Therapy Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Immuno-oncology Therapy Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Immuno-oncology Therapy Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Immuno-oncology Therapy Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Immuno-oncology Therapy Revenue Market Share (2018-2023)
    Table 23. China Based Immuno-oncology Therapy Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Immuno-oncology Therapy Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Immuno-oncology Therapy Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Immuno-oncology Therapy Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Immuno-oncology Therapy Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Immuno-oncology Therapy Revenue Market Share (2018-2023)
    Table 29. World Immuno-oncology Therapy Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Immuno-oncology Therapy Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Immuno-oncology Therapy Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Immuno-oncology Therapy Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Immuno-oncology Therapy Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Immuno-oncology Therapy Market Size by Application (2024-2029) & (USD Million)
    Table 35. Amgen Basic Information, Area Served and Competitors
    Table 36. Amgen Major Business
    Table 37. Amgen Immuno-oncology Therapy Product and Services
    Table 38. Amgen Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Amgen Recent Developments/Updates
    Table 40. Amgen Competitive Strengths & Weaknesses
    Table 41. AstraZeneca Basic Information, Area Served and Competitors
    Table 42. AstraZeneca Major Business
    Table 43. AstraZeneca Immuno-oncology Therapy Product and Services
    Table 44. AstraZeneca Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. AstraZeneca Recent Developments/Updates
    Table 46. AstraZeneca Competitive Strengths & Weaknesses
    Table 47. Bristol-Myers Squibb Basic Information, Area Served and Competitors
    Table 48. Bristol-Myers Squibb Major Business
    Table 49. Bristol-Myers Squibb Immuno-oncology Therapy Product and Services
    Table 50. Bristol-Myers Squibb Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Bristol-Myers Squibb Recent Developments/Updates
    Table 52. Bristol-Myers Squibb Competitive Strengths & Weaknesses
    Table 53. Eli-Lilly Basic Information, Area Served and Competitors
    Table 54. Eli-Lilly Major Business
    Table 55. Eli-Lilly Immuno-oncology Therapy Product and Services
    Table 56. Eli-Lilly Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Eli-Lilly Recent Developments/Updates
    Table 58. Eli-Lilly Competitive Strengths & Weaknesses
    Table 59. Roche Basic Information, Area Served and Competitors
    Table 60. Roche Major Business
    Table 61. Roche Immuno-oncology Therapy Product and Services
    Table 62. Roche Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Roche Recent Developments/Updates
    Table 64. Roche Competitive Strengths & Weaknesses
    Table 65. GlaxoSmithKline Basic Information, Area Served and Competitors
    Table 66. GlaxoSmithKline Major Business
    Table 67. GlaxoSmithKline Immuno-oncology Therapy Product and Services
    Table 68. GlaxoSmithKline Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. GlaxoSmithKline Recent Developments/Updates
    Table 70. GlaxoSmithKline Competitive Strengths & Weaknesses
    Table 71. Janssen Biotech Basic Information, Area Served and Competitors
    Table 72. Janssen Biotech Major Business
    Table 73. Janssen Biotech Immuno-oncology Therapy Product and Services
    Table 74. Janssen Biotech Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Janssen Biotech Recent Developments/Updates
    Table 76. Janssen Biotech Competitive Strengths & Weaknesses
    Table 77. Merck Basic Information, Area Served and Competitors
    Table 78. Merck Major Business
    Table 79. Merck Immuno-oncology Therapy Product and Services
    Table 80. Merck Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Merck Recent Developments/Updates
    Table 82. Merck Competitive Strengths & Weaknesses
    Table 83. Novartis Basic Information, Area Served and Competitors
    Table 84. Novartis Major Business
    Table 85. Novartis Immuno-oncology Therapy Product and Services
    Table 86. Novartis Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Novartis Recent Developments/Updates
    Table 88. Novartis Competitive Strengths & Weaknesses
    Table 89. Pfizer Basic Information, Area Served and Competitors
    Table 90. Pfizer Major Business
    Table 91. Pfizer Immuno-oncology Therapy Product and Services
    Table 92. Pfizer Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. Pfizer Recent Developments/Updates
    Table 94. Pfizer Competitive Strengths & Weaknesses
    Table 95. Sanofi Basic Information, Area Served and Competitors
    Table 96. Sanofi Major Business
    Table 97. Sanofi Immuno-oncology Therapy Product and Services
    Table 98. Sanofi Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. Sanofi Recent Developments/Updates
    Table 100. Sanofi Competitive Strengths & Weaknesses
    Table 101. Spectrum Pharmaceuticals Basic Information, Area Served and Competitors
    Table 102. Spectrum Pharmaceuticals Major Business
    Table 103. Spectrum Pharmaceuticals Immuno-oncology Therapy Product and Services
    Table 104. Spectrum Pharmaceuticals Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. Spectrum Pharmaceuticals Recent Developments/Updates
    Table 106. Spectrum Pharmaceuticals Competitive Strengths & Weaknesses
    Table 107. Takeda Basic Information, Area Served and Competitors
    Table 108. Takeda Major Business
    Table 109. Takeda Immuno-oncology Therapy Product and Services
    Table 110. Takeda Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 111. Takeda Recent Developments/Updates
    Table 112. Takeda Competitive Strengths & Weaknesses
    Table 113. BioNTech SE Basic Information, Area Served and Competitors
    Table 114. BioNTech SE Major Business
    Table 115. BioNTech SE Immuno-oncology Therapy Product and Services
    Table 116. BioNTech SE Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 117. BioNTech SE Recent Developments/Updates
    Table 118. BioNTech SE Competitive Strengths & Weaknesses
    Table 119. Allogene Therapeutics Basic Information, Area Served and Competitors
    Table 120. Allogene Therapeutics Major Business
    Table 121. Allogene Therapeutics Immuno-oncology Therapy Product and Services
    Table 122. Allogene Therapeutics Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 123. Allogene Therapeutics Recent Developments/Updates
    Table 124. Allogene Therapeutics Competitive Strengths & Weaknesses
    Table 125. IMAB-I-Mab Biopharma Co., Ltd. Basic Information, Area Served and Competitors
    Table 126. IMAB-I-Mab Biopharma Co., Ltd. Major Business
    Table 127. IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Product and Services
    Table 128. IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 129. IMAB-I-Mab Biopharma Co., Ltd. Recent Developments/Updates
    Table 130. IMAB-I-Mab Biopharma Co., Ltd. Competitive Strengths & Weaknesses
    Table 131. Arcus Biosciences Basic Information, Area Served and Competitors
    Table 132. Arcus Biosciences Major Business
    Table 133. Arcus Biosciences Immuno-oncology Therapy Product and Services
    Table 134. Arcus Biosciences Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 135. Arcus Biosciences Recent Developments/Updates
    Table 136. Arcus Biosciences Competitive Strengths & Weaknesses
    Table 137. Gritstone Oncology Basic Information, Area Served and Competitors
    Table 138. Gritstone Oncology Major Business
    Table 139. Gritstone Oncology Immuno-oncology Therapy Product and Services
    Table 140. Gritstone Oncology Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 141. Gritstone Oncology Recent Developments/Updates
    Table 142. Gritstone Oncology Competitive Strengths & Weaknesses
    Table 143. Autolus Therapeutics Basic Information, Area Served and Competitors
    Table 144. Autolus Therapeutics Major Business
    Table 145. Autolus Therapeutics Immuno-oncology Therapy Product and Services
    Table 146. Autolus Therapeutics Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 147. Autolus Therapeutics Recent Developments/Updates
    Table 148. Rubius Therapeutics Basic Information, Area Served and Competitors
    Table 149. Rubius Therapeutics Major Business
    Table 150. Rubius Therapeutics Immuno-oncology Therapy Product and Services
    Table 151. Rubius Therapeutics Immuno-oncology Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 152. Global Key Players of Immuno-oncology Therapy Upstream (Raw Materials)
    Table 153. Immuno-oncology Therapy Typical Customers
List of Figure
    Figure 1. Immuno-oncology Therapy Picture
    Figure 2. World Immuno-oncology Therapy Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Immuno-oncology Therapy Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Immuno-oncology Therapy Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Immuno-oncology Therapy Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Immuno-oncology Therapy Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Immuno-oncology Therapy Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Immuno-oncology Therapy Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Immuno-oncology Therapy Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Immuno-oncology Therapy Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Immuno-oncology Therapy Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Immuno-oncology Therapy Revenue (2018-2029) & (USD Million)
    Figure 13. Immuno-oncology Therapy Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Immuno-oncology Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Immuno-oncology Therapy Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Immuno-oncology Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Immuno-oncology Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Immuno-oncology Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Immuno-oncology Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Immuno-oncology Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Immuno-oncology Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Immuno-oncology Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Immuno-oncology Therapy by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Immuno-oncology Therapy Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Immuno-oncology Therapy Markets in 2022
    Figure 27. United States VS China: Immuno-oncology Therapy Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Immuno-oncology Therapy Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Immuno-oncology Therapy Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Immuno-oncology Therapy Market Size Market Share by Type in 2022
    Figure 31. Monoclonal Antibodies
    Figure 32. Immune Checkpoint Inhibitors
    Figure 33. Immune System Modulators
    Figure 34. Cancer Vaccines
    Figure 35. World Immuno-oncology Therapy Market Size Market Share by Type (2018-2029)
    Figure 36. World Immuno-oncology Therapy Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 37. World Immuno-oncology Therapy Market Size Market Share by Application in 2022
    Figure 38. Hospitals
    Figure 39. Ambulatory Surgical Center
    Figure 40. Others
    Figure 41. Immuno-oncology Therapy Industrial Chain
    Figure 42. Methodology
    Figure 43. Research Process and Data Source

Companies Mentioned

Amgen
AstraZeneca
Bristol-Myers Squibb
Eli-Lilly
Roche
GlaxoSmithKline
Janssen Biotech
Merck
Novartis
Pfizer
Sanofi
Spectrum Pharmaceuticals
Takeda
BioNTech SE
Allogene Therapeutics
IMAB-I-Mab Biopharma Co., Ltd.
Arcus Biosciences
Gritstone Oncology
Autolus Therapeutics
Rubius Therapeutics